Acticor Biotech recruits first patient in Covid-19 related ARDS treatment trial
The Phase II GARDEN study will enrol a total of 60 participants in France and Brazil. Credit: Robina Weermeijer on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
